Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eisai Sues DEA Over Delay In Scheduling Its Epilepsy Drug
Pharmalot
Tuesday, August 20, 2013 - 9:17am
tags:
Eisai, DEA, epilepsy, Fycompa
Sequenom cuts 75 jobs in reorganization plan
Yahoo/AP
Tuesday, August 20, 2013 - 9:14am
tags:
Sequenom, layoffs
4 Biotech Stocks Rising on Unusual Volume
TheStreet.com
Tuesday, August 20, 2013 - 9:12am
tags:
Gentium, Endo Health Solutions, INSYS Therapeutics, Osiris Therapeutics
Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
Yahoo
Tuesday, August 20, 2013 - 9:10am
tags:
JNJ, Aragon, M&A
The Deal: Onyx Trials Cloud Amgen Deal
TheStreet.com
Monday, August 19, 2013 - 10:34pm
tags:
ONYX Pharmaceuticals, Amgen, clinical trials, M&A, Kyprolis
Understanding Arena's Revenue
Seeking Alpha
Monday, August 19, 2013 - 4:09pm
tags:
Arena Pharmaceuticals, Eisai, Belviq
J&J: We Achieved A 'Major Milestone' At Our Troubled OTC Plant
Pharmalot
Monday, August 19, 2013 - 3:41pm
tags:
OTC, drug manufacturing, JNJ, recalls
Payout: More CROs Use Retention And Recruitment Bonuses
Pharmalot
Monday, August 19, 2013 - 10:53am
tags:
CROs
RxSaver™ provides 544% ROI for Pharmaceutical Brands by Solving Prescription Abandonment
CP Wire
Monday, August 19, 2013 - 10:28am
tags:
RxSaver, prescription abandonment
FTC asks to file brief in Effexor case, testing Supreme Court's pay-for-delay ruling
Fierce Pharma
Monday, August 19, 2013 - 10:25am
tags:
FTC, Effexor, Supreme Court, pay-for-delay, Teva, Wyeth
St. Jude to Buy Switzerland’s Endosense for $171 Million
Bloomberg
Monday, August 19, 2013 - 10:23am
tags:
devices, Switzerland, Endosense, M&A, St. Jude Medical
Anacor's Future Is Positive Despite Tavaborole Issues
Seeking Alpha
Monday, August 19, 2013 - 10:21am
tags:
Anacor, Tavaborole
Big Pharma Shrinks Headcount, But Biotech Hiring Compensates
Pharmalot
Monday, August 19, 2013 - 10:19am
tags:
biotech, hirings, layoffs
Confidence in ONXX/AMGN Deal
TheStreet.com
Monday, August 19, 2013 - 10:18am
tags:
ONYX Pharmaceuticals, Amgen, M&A
With Vical Out, What's Next For The Melanoma Pipeline?
Seeking Alpha
Monday, August 19, 2013 - 10:17am
tags:
Vical, melanoma, Amgen, Celsion, OncoSec, Allovectin, ImmunoPulse
Cell Therapeutics' aggressive non-hodgkin lymphoma treatment wins market access in France
Pharmaceutical Business Review
Monday, August 19, 2013 - 9:54am
tags:
non-Hodgkin's lymphoma, France, Cell Therapeutics, Pixuvri
GTx says muscle drug fails in late-stage trials
Reuters
Monday, August 19, 2013 - 9:48am
tags:
GTx, enobosarm, cancer-induced muscle wasting
Lilly set to begin critical Alimta patent dispute, WSJ says
The Fly on the Wall
Monday, August 19, 2013 - 9:46am
tags:
Eli Lilly, patents, Alimta, non-small cell lung cancer
Shire hired Lazard to fend off takeovers, SundayTimes reports
Yahoo/Fly on the Wall
Monday, August 19, 2013 - 9:45am
tags:
Shire, M&A
MannKind's Steady Progression Towards FDA Approval Continues Unabated
Seeking Alpha
Monday, August 19, 2013 - 9:43am
tags:
MannKind, FDA, Afrezza, diabetes, insulin, inhaled insulin, Eli Lilly, Pfizer, Novo Nordisk

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.